Literature DB >> 21030536

Effects of backbone substitutions on the conformational behavior of Shigella flexneri O-antigens: implications for vaccine strategy.

François-Xavier Theillet1, Catherine Simenel, Catherine Guerreiro, Armelle Phalipon, Laurence A Mulard, Muriel Delepierre.   

Abstract

The O-antigen (O-Ag), the polysaccharide part of the lipopolysaccharide, is the major target of the serotype-specific protective humoral response elicited upon host infection by Shigella flexneri, the main causal agent of the endemic form of bacillary dysentery. The O-Ag repeat units (RUs) of 12 S. flexneri serotypes share the tetrasaccharide backbone →2)-α-l-Rhap-(1 → 2)-α-l-Rhap-(1 → 3)-α-l-Rhap-(1 → 3)-β-d-GlcpNAc-(1→, with site-selective glucosylation(s) and/or O-acetylation defining the serotypes. To investigate the conformational basis of serotype specificity, we sampled conformational behaviors during 60 ns of molecular dynamic simulations for oligosaccharides representing three RUs of each one of the O-Ags corresponding to serotypes 1a, 1b, 2a, 2b, 3a, 3b, 4a, 4b, 5a, 5b, X and Y, respectively. The calculated trajectories were checked by nuclear magnetic resonance (NMR) for 1a, 2a, 3a and 5a O-Ags. The simulations predict that in all O-Ags, but 1a and 1b, serotype-specific substitutions of the backbone do not induce any new backbone conformations compared with the linear type O-Ag Y, although they restrain locally the accessible conformational space. Moreover, the influence of any given substituent on the backbone is independent of the eventual presence of other substituents. Finally, only slight differences in conformational behavior between terminal and inner RUs were observed. These results suggest that the reported serotype-specificity of the protective immune response is not due to recognition of distinct backbone conformations, but to binding of the serotype-defining substituents in the O-Ag context. The gained knowledge is discussed in terms of impact on the development of a broad-serotype coverage vaccine.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21030536     DOI: 10.1093/glycob/cwq136

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  11 in total

Review 1.  Progress and pitfalls in Shigella vaccine research.

Authors:  Eileen M Barry; Marcela F Pasetti; Marcelo B Sztein; Alessio Fasano; Karen L Kotloff; Myron M Levine
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-02-19       Impact factor: 46.802

Review 2.  Lipopolysaccharide O-antigens-bacterial glycans made to measure.

Authors:  Chris Whitfield; Danielle M Williams; Steven D Kelly
Journal:  J Biol Chem       Date:  2020-05-18       Impact factor: 5.157

3.  Bacteriophage-mediated Glucosylation Can Modify Lipopolysaccharide O-Antigens Synthesized by an ATP-binding Cassette (ABC) Transporter-dependent Assembly Mechanism.

Authors:  Evan Mann; Olga G Ovchinnikova; Jerry D King; Chris Whitfield
Journal:  J Biol Chem       Date:  2015-09-01       Impact factor: 5.157

4.  Conformational and Immunogenicity Studies of the Shigella flexneri Serogroup 6 O-Antigen: The Effect of O-Acetylation.

Authors:  Nicole Inge Richardson; Neil Ravenscroft; Vanessa Arato; Davide Oldrini; Francesca Micoli; Michelle M Kuttel
Journal:  Vaccines (Basel)       Date:  2021-04-27

Review 5.  Carbohydrates in Cyberspace.

Authors:  Elizabeth Yuriev; Paul A Ramsland
Journal:  Front Immunol       Date:  2015-06-10       Impact factor: 7.561

6.  Genome Analysis of Shigella flexneri Serotype 3b Strain SFL1520 Reveals Significant Horizontal Gene Acquisitions Including a Multidrug Resistance Cassette.

Authors:  Pawan Parajuli; Lachlan P Deimel; Naresh K Verma
Journal:  Genome Biol Evol       Date:  2019-03-01       Impact factor: 3.416

7.  Rationalizing the design of a broad coverage Shigella vaccine based on evaluation of immunological cross-reactivity among S. flexneri serotypes.

Authors:  Francesco Citiulo; Francesca Necchi; Francesca Mancini; Omar Rossi; Maria Grazia Aruta; Gianmarco Gasperini; Renzo Alfini; Simona Rondini; Francesca Micoli; Rino Rappuoli; Allan Saul; Laura B Martin
Journal:  PLoS Negl Trop Dis       Date:  2021-10-13

8.  Horizontally acquired glycosyltransferase operons drive salmonellae lipopolysaccharide diversity.

Authors:  Mark R Davies; Sarah E Broadbent; Simon R Harris; Nicholas R Thomson; Marjan W van der Woude
Journal:  PLoS Genet       Date:  2013-06-20       Impact factor: 5.917

9.  Molecular Modeling of the Shigella flexneri Serogroup 3 and 5 O-Antigens and Conformational Relationships for a Vaccine Containing Serotypes 2a and 3a.

Authors:  Jason Hlozek; Sara Owen; Neil Ravenscroft; Michelle M Kuttel
Journal:  Vaccines (Basel)       Date:  2020-11-02

Review 10.  Toward a Multivalent Synthetic Oligosaccharide-Based Conjugate Vaccine against Shigella: State-of-the-Art for a Monovalent Prototype and Challenges.

Authors:  Armelle Phalipon; Laurence A Mulard
Journal:  Vaccines (Basel)       Date:  2022-03-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.